Ovation
Ovation provides high-quality genomic data and operational solutions for life sciences, advancing precision medicine.
Founded
2017Ovation provides high-quality genomic data and operational solutions for life sciences, advancing precision medicine.
Founded to advance precision medicine, Ovation provides high-quality genomic and operational solutions for the life sciences industry. The company offers access to a wide range of consented genomic data linked to diverse, longitudinal phenotypic data at scale. Their cloud-based Laboratory Information Management System (LIMS) enables clinical labs to easily adopt innovative practices. Ovation's core mission is to support the advancement of precision medicine by helping researchers identify and validate biomarkers, discover new targets, and understand resistance mechanisms in various populations.
Ovation has attracted notable investors and industry experts who believe in its mission to transform drug discovery and development. The company's disease-specific genomic and transcriptomic data cohorts are designed to significantly increase drug discovery success rates across therapeutic areas. By providing detailed clinical information with the necessary scale, diversity, and depth, Ovation has made a substantial impact on the life sciences sector, driving forward the capabilities of precision medicine and genomics research.
Companies similar to Ovation include Genoox, Genomenon, LifeOmic and Seven Bridges.
Ovation was founded in 2017.
Ovation's headquarters is located in Cambridge, MA, US.
Ovation's most recent funding round was for $21.5M (USD) in December 2020.
As of Dec 16, 2020, Ovation has disclosed funding of $56M (USD). Undisclosed round amounts are excluded.
Ovation has 64 employees as of Feb 4, 2024.
Seven Bridges
sevenbridges.com
